α1-Syntrophin-deficient skeletal muscle exhibits hypertrophy and aberrant formation of neuromuscular junctions during regeneration

Journal of Cell Biology

Volumn 158, Issue 6, 2002, Pages 1097-1107

  Hosaka, Yukio ^a   Yokota, Toshifumi ^b   Miyagoe Suzuki, Yuko ^c   Yuasa, Katsutoshi ^c   Imamura, Michihiro ^d   Matsuda, Ryoichi ^a   Ikemoto, Takaaki ^a   Kameya, Shuhei ^e   Takeda, ShiN'Ichi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NAKADORI GENERAL HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e AKITA UNIVERSITY   (Japan)

Author keywords

1 Syntrophin; Hypertrophy; Neuromuscular junction; Regeneration; Skeletal muscle

Indexed keywords

ALPHA 1 SYNTROPHIN; AQUAPORIN 4; NITRIC OXIDE SYNTHASE; SOMATOMEDIN C; SYNTROPHIN; UNCLASSIFIED DRUG; UTROPHIN; AQP4 PROTEIN, MOUSE; AQUAPORIN; CALCIUM BINDING PROTEIN; DIRECT LYTIC FACTOR; ISOPROTEIN; MEMBRANE PROTEIN; MUSCLE PROTEIN; MYOSIN HEAVY CHAIN; SOMATOMEDIN; SYNTROPHIN ALPHA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXERCISE; MOUSE; MOUSE STRAIN; MUSCLE CONTRACTILITY; MUSCLE FORCE; MUSCLE HYPERTROPHY; MUSCLE REGENERATION; NEUROMUSCULAR SYNAPSE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN FAMILY; PROTEIN FUNCTION; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; FAST MUSCLE FIBER; GENETICS; HISTOLOGY; HYPERTROPHY; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLISM; MOUSE MUTANT; MUSCLE CONTRACTION; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE; TIME;

ANIMALIA;

ANIMALS; AQUAPORIN 4; AQUAPORINS; CALCIUM-BINDING PROTEINS; DIRECT LYTIC FACTORS; EXERTION; HYPERTROPHY; INJECTIONS, INTRAMUSCULAR; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE FIBERS, FAST-TWITCH; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; NEUROMUSCULAR JUNCTION; PROTEIN ISOFORMS; REGENERATION; SOMATOMEDINS; TIME FACTORS;

EID: 0037119629     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200204076     Document Type: Article

References (56)

1. Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution
2. Mouse alpha 1- and beta 2-syntrophin gene structure, chromosome localization, and homology with a discs large domain
3. Absence of alpha-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin
4. Analysis of skeletal and cardiac muscle from desmin knock-out and normal mice by high resolution separation of myosin heavy-chain isoforms
5. Syntrophin binds to an alternatively spliced exon of dystrophin
6. Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23-24
7. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice
8. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains
9. Myosin isozyme transitions occurring during the postnatal development of the rat soleus muscle
10. The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle
11. Identification of dystrophin-binding protein(s) in membranes from Torpedo electrocyte and rat muscle
12. Effect of voluntary wheel-running exercise on muscles of the mdx mouse
13. Pleckstrin homology domain 1 of mouse alpha 1-syntrophin binds phosphatidylinositol 4,5-bisphosphate
14. Myosin molecular motor dysfunction in dystrophic mouse diaphragm
15. The mdx mouse skeletal muscle myopathy: II. Contractile properties
16. Muscle regeneration
17. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice
18. Higher content of insulin-like growth factor-I in dystrophic mdx mouse: Potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function
19. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice
20. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy
21. Expression of aquaporin-4 in fast-twitch fibers of mammalian skeletal muscle
22. Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins
23. Subtle neuromuscular defects in utrophin-deficient mice
24. Dystrophin deficiency, altered cell signalling and fibre hypertrophy
25. Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition
26. Differential expression of dystrophin isoforms and utrophin during dibutyryl-cAMP-induced morphological differentiation of rat brain astrocytes
27. A specific force deficit exists in skeletal muscle after partial denervation
28. Alpha1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration
29. Nitric oxide in skeletal muscle
30. Association of utrophin and multiple dystrophin short forms with the mammalian M(r) 58,000 dystrophin-associated protein (syntrophin)
31. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy
32. Immunocytochemical studies of aquaporin 4 in the skeletal muscle of mdx mouse
33. Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old
34. Dystrophin-associated proteins in muscular dystrophy
35. Animal models of muscular dystrophy-what can they teach us?
36. Differential association of syntrophin pairs with the dystrophin complex
37. Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells
38. Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent
39. Culturing satellite cells from living single muscle fiber explant
40. Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels
41. Localization ofdystrophin relative to acetylcholine receptor domains in electric tissue and adult and cultured skeletal muscle
42. Abnormalities in alpha-, beta- and gamma-sarcoglycan in patients with limb-girdle muscular dystrophy
43. Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle
44. Physiology of nitric oxide in skeletal muscle
45. MAGI-1c: A synaptic MAGUK interacting with MuSK at the vertebrate neuromuscular junction
46. Mammalian alpha 1- and beta 1-syntrophin bind to the alternative splice-prone region of the dystrophin COOH terminus
47. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle
48. Evaluation of animal models for the study of exercise-induced muscle enlargement
49. PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands
50. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain
51. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice
52. Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy
53. Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin
54. Aquaporin-4 is absent at the sarcolemma and at perivascular astrocyte endfeet in α1-syntrophin knockout mice
55. Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy
56. Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses